Contact us

Want to get in touch with Vernalis? Here’s where you’ll find contact information for our offices, with maps and directions if you are coming to visit. There’s also a form to complete in order to contact us remotely. 

  • Head office and development, based near Reading
  • US commercial operations in Berwyn, Pennsylvania
  • Research operations based near Cambridge

If you require medical information on any of our products please email medical@vernalis.com

If you have a query regarding your shareholding, please email Capita Asset Services at shareholderenquiries@capita.co.uk


Want to get in touch?

Here are the principal points of contact

Contact information


Visiting Vernalis?

Here’s how to find us

Maps and directions


Want to make an enquiry?

Start with our contact form

Contact form

Latest News

Results Announcement for the year ended 30 June 2017

Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.

 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch